Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Arev, Marija"'
(I.) The aim of the study The purpose of this study is to utilize previous research on the formulation of conjugated antibodies as radiopharmaceuticals utilizing beta emitters, and to apply this knowledge to the development of immunoconjugates suitab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::c3124261a536e5dcaa5a7e5d4e73ae3a
https://eprints.ugd.edu.mk/31769/
https://eprints.ugd.edu.mk/31769/
Autor:
Karpicarov, Dino, Apostolova, Paulina, Arev, Marija, Arsova-Sarafinovska, Zorica, Gjorgjeska, Biljana
The principal aim of this paper is to establish and validate a rapid, simple, and economical approach that employs high-pressure liquid chromatography, capable of routinely assessing the content of Meloxicam present in injections. To accomplish this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::b34f813ca4723f862c61638db4475a14
https://eprints.ugd.edu.mk/31666/
https://eprints.ugd.edu.mk/31666/
Development and Validation of HPLC method for determination of Methylprednisolone aceponate in cream
Autor:
Apostolova, Paulina, Karpicarov, Dino, Arev, Marija, Janevik-Ivanovska, Emilija, Gjorgjeska, Biljana, Arsova-Sarafinovska, Zorica
Methylprednisolone aceponate (MPA) is an active pharmaceutical ingredient (API), used as a potent topical glucocorticoid that treats various types of eczema and psoriasis. Compared to other glucocorticoids, MPA has high efficiency and reduced applica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9754ded4aa69806878f6d5176643bebd
https://eprints.ugd.edu.mk/30820/
https://eprints.ugd.edu.mk/30820/
Autor:
Arev, Marija, Vranjes-Duric, Sanja, Jankovic, Drina, Mirkovic, Marija, Radovic, Magdalena, Apostolova, Paulina, Janevik-Ivanovska, Emilija
Aim The aim of this study is to present the part of our project dedicated to obtaining a stable, ready to use freeze dried kit formulation of antibody radioimmunoconjugates (trastuzumab immunoconjugates labelled with 90Y and 177Lu). As the first step
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::c6bce2407784493ba57998d70a2a8b76
https://eprints.ugd.edu.mk/30610/
https://eprints.ugd.edu.mk/30610/
Small animal model in the development of radiopharmaceuticals - the step forward to clinical studies
Autor:
Janevik-Ivanovska, Emilija, Gjorgoski, Icko, Aleksovski, Boris, Tripunoski, Toni, Darkovska-Serafimovska, Marija, Smilkov, Katarina, Gjorgieva Ackova, Darinka, Arev, Marija, Apostolova, Paulina, Baloch, Lajos
Experimental design is obviously a critical component for the success of any research activities concerning development and evaluation of new radiopharmaceuticals. The development of new generation of radiolabeled molecules and technologies (SPECT/PE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::8993e76242ecaf3c5f9f652b2b839742
https://eprints.ugd.edu.mk/30609/
https://eprints.ugd.edu.mk/30609/
Radioimmunoconjugates consist of a monoclonal antibody (mAb) linked to a radionuclide. Monoclonal antibodies (mAbs) are immunoglobulins able to recognize unique epitopes on a single antigen. MAbs therapy has emerged as a significant therapeutic choic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::5a0d6fede56ec4f1ec85521e76e1a948
https://eprints.ugd.edu.mk/30203/
https://eprints.ugd.edu.mk/30203/
Autor:
Arev, Marija S.
Publikováno v:
Универзитет у Нишу
Monoclonal antibody-based therapy is one of the most successful therapeutic approaches for solid tumors and other malignancies. Radiolabeling of antibodies with radioisotopes provides development of selective and specific radiopharmaceuticals with be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=nardusnacion::ed8919371f6daa092f9b963dac6e8ec6
http://nardus.mpn.gov.rs/bitstream/id/148373/Doctoral_thesis_12915.pdf
http://nardus.mpn.gov.rs/bitstream/id/148373/Doctoral_thesis_12915.pdf
Monoclonal antibody Trastuzumab is the first humanized approved antibody for tratment of HER-2 positive breast cancer. Led by its promising indication, we made further improvemetns to prepare freeze-dried immunogates with bifunctional chelators, read
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::16c346f2e3431110625443e02e170ba0
https://eprints.ugd.edu.mk/29470/
https://eprints.ugd.edu.mk/29470/
Autor:
Mwanza Wanjeh, David, Aschalew Alemu, Marie, Arev, Marija, Arsova-Sarafinovska, Zorica, Apostolova, Paulina, Janevik-Ivanovska, Emilija
Monoclonal antibodies (mAbs) are currently assessed as a significant and growing class of drugs of biological origin. The goal of our investigation was to introduce and standardize an available protocol for freeze-drying a formulation of the conjugat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aedb425d668fdc43850de0139d3a331b
http://eprints.ugd.edu.mk/23947/
http://eprints.ugd.edu.mk/23947/
Autor:
Arev, Marija, Dzodic, Predrag, Dimovski, Aleksandar, Davalieva, Katarina, Kiprijanovska, Sanja, Drakalska, Elena, Janevik-Ivanovska, Emilija
Aims: The importance of trastuzumab (Tr) conjugation with bifunctional chelators (BFCs) in different molar ratio are presented with this study. A successful radiolabeling can be achieved after binding of optimal number of BFCs (4-5) per monoclonal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2788::5b52cd1ab3e73d389955d6deb353afd6
https://eprints.ugd.edu.mk/22968/
https://eprints.ugd.edu.mk/22968/